SignatureFD
ACAD icon

SignatureFD’s Acadia Pharmaceuticals ACAD Stock Holding History

SignatureFD’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10K Buy
497
+221
+80% +$5.93K ﹤0.01% 2727
2026
Q2 		$6.98K Buy
276
+102
+59% +$2.24K ﹤0.01% 2769
2026
Q1 		$3.87K Buy
174
+82
+89% +$1.96K ﹤0.01% 2865
2025
Q4 		$2.46K Hold
92
– – ﹤0.01% 2915
2025
Q3 		$1.96K Buy
92
+11
+14% +$260 ﹤0.01% 2956
2025
Q2 		$1.75K Buy
+81
New +$1.51K ﹤0.01% 2903
2025
Q1 		– Sell
-41
Closed -$752 – 3322
2024
Q4 		$752 Sell
41
-363
-90% -$5.86K ﹤0.01% 3080
2024
Q3 		$6.21K Hold
404
– – ﹤0.01% 2505
2024
Q2 		$6.56K Buy
404
+381
+1,657% +$6.15K ﹤0.01% 2422
2024
Q1 		$425 Sell
23
-27
-54% -$669 ﹤0.01% 3043
2023
Q4 		$1.57K Buy
50
+8
+19% +$191 ﹤0.01% 2825
2023
Q3 		$875 Hold
42
– – ﹤0.01% 2953
2023
Q2 		$1.01K Buy
+42
New +$934 ﹤0.01% 2973
2022
Q4 		– Sell
-20
Closed – – 3279
2022
Q3 		$0 Sell
20
-69
-78% -$1.12K ﹤0.01% 3088
2022
Q2 		$1K Sell
89
-3
-3% -$56 ﹤0.01% 2860
2022
Q1 		$2K Sell
92
-8
-8% -$194 ﹤0.01% 2757
2021
Q4 		$2K Buy
+100
New +$2.01K ﹤0.01% 2659
2021
Q3 		– Sell
-420
Closed -$10K – 3015
2021
Q2 		$10K Buy
420
+266
+173% +$6K ﹤0.01% 1964
2021
Q1 		$4K Buy
154
+98
+175% +$4.31K ﹤0.01% 2197
2020
Q4 		$3K Buy
+56
New +$2.78K ﹤0.01% 2095
2020
Q3 		– Sell
-42
Closed -$2K – 2581
2020
Q2 		$2K Buy
+42
New +$2.02K ﹤0.01% 2065

Other funds holding ACAD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

SignatureFD's ACAD Position: Q3 2026 in Review

SignatureFD increased its Acadia Pharmaceuticals (ACAD) stake by 80% in Q3 2026, buying an estimated $5.93K and bringing the position to 497 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

SignatureFD first reported a position in ACAD in Q2 2020 and has held it in 21 quarters since. 263 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • SignatureFD held 497 shares of Acadia Pharmaceuticals worth $10K as of Q3 2026.
  • SignatureFD bought 221 Acadia Pharmaceuticals shares in Q3 2026, an estimated $5.93K.
  • Acadia Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2727 holding.
  • SignatureFD first reported a position in Acadia Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • 263 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.